Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11661753 | 1.00 | TSHR (0.53) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL6107195 | 1.00 | TSHR (0.53) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL11690578 | 1.00 | TSHR (0.53) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL3277853 | 1.00 | TSHR (0.53) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL305825 | 1.00 | TSHR (0.53) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL10318693 | 1.00 | TSHR (0.53) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL699509 | 1.00 | — | — | |
| SCHEMBL8447776 | 1.00 | TSHR (0.53) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL146783 | 1.00 | — | — | |
| SCHEMBL31181884 | 1.00 | TSHR (0.53) | TSHRTHRBALDH1A1DNM1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025242747-A1 | MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS | MERCK PATENT GMBH (DE) | 2025-11-27 | — | — | WO | claimed |
| CN-119059795-B | Preparation method of phenolic aerogel composite heat insulation tile | 山东工业陶瓷研究设计院有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-119191865-A | Short fiber carbon ceramic composite material brake disc and preparation method thereof | 山东旌丞新材料科技有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-119059795-A | Preparation method of phenolic aerogel composite heat insulation tile | 山东工业陶瓷研究设计院有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-118561305-B | High-heat-conductivity high-purity spherical magnesium oxide precursor and preparation method thereof | 山东工业陶瓷研究设计院有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118561303-B | Low-cost high-purity high-densification spherical magnesia powder and preparation method thereof | 山东工业陶瓷研究设计院有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118561305-A | High-heat-conductivity high-purity spherical magnesium oxide precursor and preparation method thereof | 山东工业陶瓷研究设计院有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118561303-A | Low-cost high-purity high-densification spherical magnesia powder and preparation method thereof | 山东工业陶瓷研究设计院有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-113403150-B | Method for cleaning, killing and killing air-conditioning pipeline of cigarette factory | 河南省紫风养护发展有限公司 | 2022-07-05 | — | — | CN | claimed |
| CN-113403150-A | Method for cleaning, eliminating and killing air-conditioning pipeline of cigarette factory | 河南省紫风养护发展有限公司 | 2021-09-17 | — | — | CN | claimed |
| US-7273948-B2 | Process of preparing esters and ethers of probucol and derivatives thereof | ATHEROGENICS, INC. (US) | 2007-09-25 | — | — | US | claimed |
| EP-1594824-A4 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | ATHEROGENICS INC (US) | 2007-04-04 | — | — | EP | claimed |
| EP-1594824-A2 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | Atherogenics, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| US-20040204485-A1 | Process of preparing esters and ethers of probucol and derivatives thereof | CRABTREE ACQUISITION CO, LLC | 2004-10-14 | — | — | US | claimed |
| WO-2004062622-A2 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | ATHEROGENICS, INC. (US) | 2004-07-29 | — | — | WO | claimed |
| WO-2025242747-A1 | MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS | MERCK PATENT GMBH (DE) | 2025-11-27 | — | — | WO | disclosed |
| US-20250312287-A1 | LIPID NANOPARTICLES COMPRISING AN IMIDAZOLIUM-BASED CATIONIC LIPID | POLYPLUS TRANSFECTION (FR) | 2025-10-09 | — | — | US | disclosed |
| US-5414133-A | Protected phosphine oxides | CIBA-GEIGY CORPORATION (US) | 1995-05-09 | — | — | US | disclosed |
| US-5298663-A | Process for the preparation of protected phosphine oxides | CIBA-GEIGY CORPORATION (US) | 1994-03-29 | — | — | US | disclosed |
| EP-0501702-A2 | Process for the preparation of protected phosphine oxides | CIBA-GEIGY AG (CH) | 1992-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250312287-A1 | LIPID NANOPARTICLES COMPRISING AN IMIDAZOLIUM-BASED CATIONIC LIPID | NPC1L1, CETP, LNPK | TSHR 486/4885THRB 1110/4885ALDH1A1 4418/4885 |
| US-20040204485-A1 | Process of preparing esters and ethers of probucol and derivatives thereof | NR3C2, MGLL, GCG | TSHR 1000/4885THRB 269/4885ALDH1A1 2574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.